Read + Share
Mahase E. Depression: EU approves expanded use of esketamine for rapid reduction of
symptoms. BMJ 2021;372:n398.
PMID: 33568423
|
 |
|
Mahase E. Depression: EU approves expanded use of esketamine for rapid reduction of
symptoms. BMJ 2021;372:n398.
PMID: 33568423
|
|
|
|